一种工程自生物矿物化瘤性腺病毒诱导有效的抗瘤免疫力,并与免疫检查点阻塞协同作用
Shibing Wang1,2, Xue Yang2,3, Ying-Yu Ma2,3
1Department of Clinical Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Cancer immunology research
|August 2, 2024
概括
瘤性腺病毒 (oADV) 与W6p的自我生物矿化产生了矿化的oADV-W6-CaP. 这种增强的oADV改善了癌细胞感染,免疫反应和瘤清除,显示了癌症免疫治疗的前景.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤性腺病毒 (oADV) 显示出治疗潜力,但面临诸如肝脏封存和免疫反应等挑战.
- 提高oADV感染效率和克服宿主免疫力对于有效的癌症治疗至关重要.
研究的目的:
- 开发一种自我生物矿化策略,以增强oADV感染,免疫性和治疗疗效.
- 调查矿化oADVs在克服CAR阴性癌细胞障碍和预先存在的中和抗体方面的潜力.
主要方法:
- 通过逆遗传学将生物模拟核W6p集成到oADV囊中.
- 在生理条件下的oADV表面诱导酸盐矿化,产生oADV-W6-CaP.
- 在CAR阴性癌细胞和皮下小鼠瘤模型中对oADV-W6-CaP的评估.
主要成果:
- oADV-W6-CaP在CAR阴性癌细胞中显示出增强的感染效率和治疗疗效.
- 在小鼠模型中,对oADV-W6-CaP的系统注射显示了抗瘤效果的提高,T细胞透的增加和CD8+T细胞的激活.
- 免疫反应依赖于CD8+T细胞,调解长期免疫记忆和全身抗瘤免疫.
- 与PD1或CD47抑制的联合治疗进一步增强了抗癌效果和瘤清除.
结论:
- 对oADVs的自我生物矿化提供了一种新的策略,以增强其在癌症治疗中的治疗潜力.
- oADV-W6-CaP有效地向CAR阴性瘤,逃避抗体中和,并将瘤微环境从"冷"转变为"热".
- 这种方法与免疫检查点封锁协同作用,突出了其对晚期癌症免疫治疗的承诺.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response
865
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
865
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
